Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure–Affinity Relationship (SAfiR) and Structure–Activity Relationship (SAR) Studies-Reference-Cited by-同舟云学术

Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure–Affinity Relationship (SAfiR) and Structure–Activity Relationship (SAR) Studies

Published:2017-06-30 Issue:24 Volume:60 Page:9913-9931
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Spinelli Francesco¹^ORCID,Capparelli Elena²³,Abate Carmen¹,Colabufo Nicola A.¹²,Contino Marialessandra¹^ORCID

Affiliation:

1. Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy

2. Biofordrug srl, Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, 70125, Bari, Italy

3. Catholic University “Our Lady of Good Counsel”, Kompleksi Spitalor Universitar “Zoja e Këshillit të Mirë”, Rr. Dritan Hoxha, Laprakë, 1000, Tirana, Albania

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b00155

Reference77 articles.

1. The molecular logic of endocannabinoid signalling

2. Cannabinoid Receptor Signaling

3. The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders

4. Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

5. Review: Activation patterns of microglia and their identification in the human brain

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands;European Journal of Medicinal Chemistry;2024-09

2. Cannabinoid receptors as new targets for HTLV-1 associated myelopathy (HAM/TSP) treatment;Multiple Sclerosis and Related Disorders;2024-07

3. Discovery of Latent Cannabichromene Cyclase Activity in Marine Bacterial Flavoenzymes;ACS Synthetic Biology;2024-03-08

4. Research progress on the cannabinoid type-2 receptor and Parkinson’s disease;Frontiers in Aging Neuroscience;2024-01-08

5. ALPACA: A machine Learning Platform for Affinity and selectivity profiling of CAnnabinoids receptors modulators;Computers in Biology and Medicine;2023-09